LITIMIC Trademark Status Change
Summary
The USPTO has recorded a status change for the LITIMIC trademark application (TM99165165), which covers various pharmaceutical preparations. The status change is noted with an effective date of March 22, 2026.
What changed
The United States Patent and Trademark Office (USPTO) has updated the status of the trademark application TM99165165, associated with the mark LITIMIC. This application covers a broad range of pharmaceutical preparations, including vaccines, anti-infectives, and treatments for numerous diseases and disorders affecting various bodily systems. The status change is effective March 22, 2026.
This update signifies a procedural step in the trademark application process. For companies involved in pharmaceuticals, this indicates a potential new entrant or a change in the branding landscape for specific therapeutic areas. No immediate compliance actions are required for other entities, but monitoring trademark filings is advisable for competitive intelligence and potential future conflicts.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
LITIMIC
Status Change TM99165165 Kind: other Mar 22, 2026
Abstract
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, obesity, and infectious
diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiopulmonary,
genitourinary, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and
immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
Filing Date
2025-05-01
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.